2016: year of the US biosimilar approval
With four biosimilars now approved in the US, the sector is growing in confidence says a BMI Research analyst.
With four biosimilars now approved in the US, the sector is growing in confidence says a BMI Research analyst.
Repligen has bought Novasep subsidiary TangenX Technology for $39m, adding single-use tangential flow filtration (TFF) cassettes to its downstream offering.
DuPont has joined a Gates Foundation backed effort to develop low cost production methods for therapeutic proteins.
XenoGesis has upgraded its spectroscopy capabilities in a deal with Thermo Fisher Scientific Inc.